Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart ...

Committee for Medicinal Products for Human Use (CHMP) has recommended an update to Novo Nordisk’s Wegovy (semaglutide 2.4 mg) ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

Novo Nordisk said that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a ...

Bagsværd, Denmark Saturday, September 21, 2024, 15:00 Hrs [IST] ...

The company noted that Wegovy is the first obesity medication ... following a linguistic review process by the EMA. As communicated earlier this year, Novo Nordisk will resubmit to the US Food ...

It’s a brain disease,” a prominent obesity doctor explained on a “60 Minutes” episode about the drugs. “Obesity is disease” ...

The latest health news covers the European Medicines Agency supporting Novo Nordisk’s drug for heart failure in obese ...

This summary of recent health news includes U.S. Senator Bernie Sanders advocating for cheaper Ozempic, new findings on ...

Wegovy received approval from South Korea’s Ministry of Food and Drug Safety in April 2023 for weight management in adults ...

The world's biggest food company is targeting Ozempic users with small, protein-packed meals for under $5.